XSTOSIMRIS B
Market cap2mUSD
Dec 23, Last price
0.09SEK
1D
71.31%
1Q
-24.89%
Jan 2017
-99.42%
IPO
-99.50%
Name
Simris Group AB
Chart & Performance
Profile
Simris Alg AB (publ) manufactures and sells dietary supplements and algae-based foods in Sweden and internationally. It offers Simris Algae Omega-3, a plant-based marine omega-3 EPA and DHA line; and a line of algae-based products, such as finest chlorella, spirulina sprinkles, boosting astaxanthin, flower power algae tea, and sun candy algae tea under the Simris Select brand. The company was founded in 2010 and is headquartered in Hammenhög, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 4,354 6.72% | 4,080 -33.52% | 6,137 183.33% | |||||||
Cost of revenue | 2,347 | 15,687 | 20,610 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,007 | (11,607) | (14,473) | |||||||
NOPBT Margin | 46.10% | |||||||||
Operating Taxes | (3,317) | (1,344) | 13 | |||||||
Tax Rate | ||||||||||
NOPAT | 5,324 | (10,263) | (14,486) | |||||||
Net income | (37,305) 52.75% | (24,422) -13.87% | (28,356) 10.75% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 39,271 | 28,127 | 201 | |||||||
BB yield | -76.34% | -75.23% | -0.33% | |||||||
Debt | ||||||||||
Debt current | 1,207 | 570 | 1,321 | |||||||
Long-term debt | 1,462 | 1,559 | 1,808 | |||||||
Deferred revenue | 1,808 | |||||||||
Other long-term liabilities | 89,278 | 89,921 | (1,808) | |||||||
Net debt | (2,996) | (1,865) | 2,168 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (36,353) | (18,188) | (18,137) | |||||||
CAPEX | (1,611) | (22,382) | (253) | |||||||
Cash from investing activities | (1,611) | (22,382) | (253) | |||||||
Cash from financing activities | 39,635 | 43,603 | 2,839 | |||||||
FCF | (4,732) | 4,588 | (3,437) | |||||||
Balance | ||||||||||
Cash | 5,665 | 3,994 | 961 | |||||||
Long term investments | ||||||||||
Excess cash | 5,447 | 3,790 | 654 | |||||||
Stockholders' equity | (92,664) | (70,547) | (56,074) | |||||||
Invested Capital | 210,225 | 185,612 | 77,424 | |||||||
ROIC | 2.69% | |||||||||
ROCE | 1.24% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 228,627 | 148,651 | 119,059 | |||||||
Price | 0.23 -10.54% | 0.25 -50.65% | 0.51 -48.42% | |||||||
Market cap | 51,441 37.60% | 37,386 -38.38% | 60,672 -44.80% | |||||||
EV | 48,445 | 35,521 | 62,840 | |||||||
EBITDA | 16,276 | (4,955) | (8,670) | |||||||
EV/EBITDA | 2.98 | |||||||||
Interest | 3,990 | 1,109 | 616 | |||||||
Interest/NOPBT | 198.80% |